Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Cathomas

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Swiss Medical Weekly|June 15, 2010
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effortRichard Cathomas, Daniel Helbling, Frank Stenner, et al.
Swiss Medical Weekly|October 27, 2024
Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficienciesJeroen S Goede, Christa K Baumann, Richard Cathomas, et al.
European Urology|January 14, 2014
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)Christian Rothermundt, Stefanie Hayoz, Arnoud J Templeton, et al.
European Urology Focus|November 15, 2022
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic ReviewAnne Neuenschwander, Chiara Lonati, Luca Antonelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2024
Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparisonKristen Johnson, Barbara Stoffel, Michael Schwitter, et al.
Urologic Oncology|September 11, 2024
Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levelsChristian D Fankhauser, Marian S Wettstein, Ailsa J Christiansen, et al.
Cancers|August 28, 2025
Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric AnalysisVerena Petermichl, Stefan Fuchs, Matthias Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2018
Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group RegistryRichard Cathomas, Dirk Klingbiel, Brandon Bernard, et al.
European Urology Focus|October 9, 2023
Prospective Multicenter Validation of the Stockholm3 Test in a Central European CohortAnas Elyan, Karim Saba, August Sigle, et al.
Frontiers in Oncology|December 26, 2022
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrenceAilsa J Christiansen, João Lobo, Christian D Fankhauser, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Swiss Medical Weekly|June 15, 2010
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effortRichard Cathomas, Daniel Helbling, Frank Stenner, et al.
Swiss Medical Weekly|October 27, 2024
Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficienciesJeroen S Goede, Christa K Baumann, Richard Cathomas, et al.
European Urology|January 14, 2014
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)Christian Rothermundt, Stefanie Hayoz, Arnoud J Templeton, et al.
European Urology Focus|November 15, 2022
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic ReviewAnne Neuenschwander, Chiara Lonati, Luca Antonelli, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2024
Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparisonKristen Johnson, Barbara Stoffel, Michael Schwitter, et al.
Urologic Oncology|September 11, 2024
Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levelsChristian D Fankhauser, Marian S Wettstein, Ailsa J Christiansen, et al.
Cancers|August 28, 2025
Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric AnalysisVerena Petermichl, Stefan Fuchs, Matthias Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2018
Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group RegistryRichard Cathomas, Dirk Klingbiel, Brandon Bernard, et al.
European Urology Focus|October 9, 2023
Prospective Multicenter Validation of the Stockholm3 Test in a Central European CohortAnas Elyan, Karim Saba, August Sigle, et al.
Frontiers in Oncology|December 26, 2022
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrenceAilsa J Christiansen, João Lobo, Christian D Fankhauser, et al.
Pageof 14